These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24457529)

  • 1. Dietary herb extract rikkunshi-to ameliorates gastroparesis in Parkinson's disease: a pilot study.
    Doi H; Sakakibara R; Sato M; Hirai S; Masaka T; Kishi M; Tsuyusaki Y; Tateno A; Tateno F; Takahashi O; Ogata T
    Eur Neurol; 2014; 71(3-4):193-5. PubMed ID: 24457529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nizatidine ameliorates gastroparesis in Parkinson's disease: a pilot study.
    Doi H; Sakakibara R; Sato M; Hirai S; Masaka T; Kishi M; Tsuyusaki Y; Tateno A; Tateno F; Takahashi O; Ogata T
    Mov Disord; 2014 Apr; 29(4):562-6. PubMed ID: 24375669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
    Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O
    J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
    Soykan I; Sarosiek I; Shifflett J; Wooten GF; McCallum RW
    Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed gastric emptying in Parkinson's disease.
    Marrinan S; Emmanuel AV; Burn DJ
    Mov Disord; 2014 Jan; 29(1):23-32. PubMed ID: 24151126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease.
    Triadafilopoulos G; Gandhy R; Barlow C
    Parkinsonism Relat Disord; 2017 Nov; 44():33-37. PubMed ID: 28847681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
    Dutta U; Padhy AK; Ahuja V; Sharma MP
    Trop Gastroenterol; 1999; 20(3):116-9. PubMed ID: 10695417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
    Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
    Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.
    Epprecht L; Schreglmann SR; Goetze O; Woitalla D; Baumann CR; Waldvogel D
    J Neurol; 2015 Aug; 262(8):1946-53. PubMed ID: 26048686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
    Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
    McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
    Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: a pilot study.
    Nakamura T; Ishii M; Arai Y; Tandoh Y; Terada A; Takebe K
    Clin Ther; 1994; 16(6):989-99. PubMed ID: 7697695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
    Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroparesis and Parkinson's disease: a systematic review.
    Heetun ZS; Quigley EM
    Parkinsonism Relat Disord; 2012 Jun; 18(5):433-40. PubMed ID: 22209346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.